Clinical Trial Update: Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance [Phase 2]

View source ↗

Summary

Phase 2 trial update on apalutamide for prostate cancer patients under active surveillance has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• Apalutamide (apalutamide)

Snippet

Sponsor: University of Washington | Conditions: Prostate Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2021-03-29